{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:46:47Z","timestamp":1774266407550,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.pnpbp.2009.06.010","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T04:33:38Z","timestamp":1245386018000},"page":"1147-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: A multicenter, prospective, naturalistic, open-label trial"],"prefix":"10.1016","volume":"33","author":[{"given":"Young Sup","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Myong","family":"Bahk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-In","family":"Jon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Ho","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Seok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Keun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hee","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Ho","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yil-Seob","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yooni","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Joon","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2009.06.010_bib1","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/j.1950-6945.2001.tb00387.x","article-title":"Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG.","volume":"3","author":"Bisuli","year":"2001","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18\u00a0month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-200427030-00002","article-title":"Safety and tolerability of lamotrigine for bipolar disorder","volume":"27","author":"Bowden","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1528-1157.2002.45401.x","article-title":"Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy","volume":"43","author":"Brodie","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib10","first-page":"474","article-title":"Race\u2013sex values of serum creatine-phosphokinase, uric acid, urea nitrogen and creatinine","volume":"5","author":"Casey","year":"1968","journal-title":"Ala J Med Sci"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.160.1.112","article-title":"Obesity as a correlate of outcome in patients with bipolar I disorder","volume":"160","author":"Fagiolini","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","article-title":"A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder","volume":"65","author":"Goodwin","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/00912709922007949","article-title":"Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy","volume":"39","author":"Grasela","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefic considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib16","series-title":"ECDEU assessment manual for psycho-pharmacology, revised","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1167.2006.00423.x","article-title":"Predictors of lamotrigine-associated rash","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2125.1997.00594.x","article-title":"Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data","volume":"43","author":"Hussein","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib21","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.55.4.588","article-title":"Adding valproate to lamotrigine: a study of their pharmacokinetic interaction","volume":"5","author":"Kanner","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4088\/JCP.v66n0516","article-title":"Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash","volume":"66","author":"Ketter","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib24","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1001\/jama.2008.890","article-title":"FDA: epilepsy drugs may carry skin risks for Asians","volume":"300","author":"Kuehn","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson syndrome. Ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B\u204e1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"45","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib27","series-title":"Global burden of disease and risk factors","article-title":"The burden of disease and mortality by condition: data, methods, and results for 2001","author":"Mathers","year":"2006"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety review of adult clinical trial experience with lamotrigine","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Saf"},{"issue":"suppl 5","key":"10.1016\/j.pnpbp.2009.06.010_bib29","first-page":"4","article-title":"An analysis of the efficacy of treatments for bipolar depression","volume":"69","author":"Nierenberg","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2165\/00023210-199708050-00002","article-title":"Drug-induced switching in bipolar disorder: epidemiology and therapeutic implications","volume":"8","author":"Post","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FTD.0b013e31817fd4d4","article-title":"Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy","volume":"30","author":"Rivas","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","article-title":"How TCRs bind MHCs, peptides, and coreceptors","volume":"24","author":"Rudolph","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0006-3223(00)00980-X","article-title":"Bipolar depression: pharmacotherapy and related therapeutic strategies","volume":"48","author":"Thase","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.06.010_bib35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"The effect of antiepileptic drug co-medication on lamotrigine clearance","volume":"62","author":"Weintraub","year":"2005","journal-title":"Arch Neurol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609001997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609001997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:40:48Z","timestamp":1759520448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584609001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0278584609001997"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.06.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: A multicenter, prospective, naturalistic, open-label trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}